133 related articles for article (PubMed ID: 38288538)
1. The Risk of COVID-19 and Its Outcomes in Korean Patients With Gout: A Multicenter, Retrospective, Observational Study.
Kim MJ; Ryu B; Park EG; Yi S; Kim K; Park JW; Shin K
J Korean Med Sci; 2024 Jan; 39(4):e37. PubMed ID: 38288538
[TBL] [Abstract][Full Text] [Related]
2. Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study.
Xie D; Choi HK; Dalbeth N; Wallace ZS; Sparks JA; Lu N; Zeng C; Li X; Wei J; Lei G; Zhang Y
Arthritis Rheumatol; 2023 Jan; 75(1):122-132. PubMed ID: 36082457
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 vaccine effectiveness and clinical outcomes in hemodialysis patients: the NHIS-COVID-19 cohort study in South Korea.
Lee YK; Jeong SA; Park HC; Kim DH; Yoo KD; Yoon HE; Kim YG; Cho A
Front Public Health; 2024; 12():1372525. PubMed ID: 38784571
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, Risk Factors, and Outcomes of Gout Flare in Patients Hospitalized for PCR-Confirmed COVID-19: A Multicenter Retrospective Cohort Study.
Jatuworapruk K; Satpanich P; Robinson PC; Grainger R
J Rheumatol; 2023 Apr; 50(4):556-563. PubMed ID: 36379566
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Coronavirus Disease 2019 in People Living With Human Immunodeficiency Virus in South Korea: A Nationwide Population-Based Cohort Study.
Kim JY; Jeong Y; An H; Suh JW; Sohn JW; Yoon YK
Influenza Other Respir Viruses; 2024 Jun; 18(6):e13337. PubMed ID: 38857604
[TBL] [Abstract][Full Text] [Related]
7. `Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea.
Jeong H; Choi E; Suh A; Yoo M; Kim B
Rheumatol Int; 2023 Feb; 43(2):265-281. PubMed ID: 36346443
[TBL] [Abstract][Full Text] [Related]
8. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.
Kim SW; Kim SM; Kim YK; Kim JY; Lee YM; Kim BO; Hwangbo S; Park T
J Korean Med Sci; 2021 Jan; 36(1):e12. PubMed ID: 33398946
[TBL] [Abstract][Full Text] [Related]
10. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.
Lee SW; Ha EK; Yeniova AÖ; Moon SY; Kim SY; Koh HY; Yang JM; Jeong SJ; Moon SJ; Cho JY; Yoo IK; Yon DK
Gut; 2021 Jan; 70(1):76-84. PubMed ID: 32732368
[TBL] [Abstract][Full Text] [Related]
11. Hospitalised COVID-19 patients of the Mount Sinai Health System: a retrospective observational study using the electronic medical records.
Wang Z; Zheutlin A; Kao YH; Ayers K; Gross S; Kovatch P; Nirenberg S; Charney A; Nadkarni G; De Freitas JK; O'Reilly P; Just A; Horowitz C; Martin G; Branch A; Glicksberg BS; Charney D; Reich D; Oh WK; Schadt E; Chen R; Li L
BMJ Open; 2020 Oct; 10(10):e040441. PubMed ID: 33109676
[TBL] [Abstract][Full Text] [Related]
12. Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study.
Lee SW; Yang JM; Moon SY; Yoo IK; Ha EK; Kim SY; Park UM; Choi S; Lee SH; Ahn YM; Kim JM; Koh HY; Yon DK
Lancet Psychiatry; 2020 Dec; 7(12):1025-1031. PubMed ID: 32950066
[TBL] [Abstract][Full Text] [Related]
13. Gout as a risk factor for osteoporosis: A Korean population-based study.
Kim JH; Kim SR; Kang G; Choi IA
Medicine (Baltimore); 2022 Nov; 101(45):e31524. PubMed ID: 36397454
[TBL] [Abstract][Full Text] [Related]
14. Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study.
Lee SW; Kim SY; Moon SY; Yang JM; Ha EK; Jee HM; Shin JI; Cho SH; Yon DK; Suh DI
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2262-2271.e2. PubMed ID: 33931377
[TBL] [Abstract][Full Text] [Related]
15. Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study.
Richard L; Booth R; Rayner J; Clemens KK; Forchuk C; Shariff SZ
CMAJ Open; 2021; 9(1):E1-E9. PubMed ID: 33436450
[TBL] [Abstract][Full Text] [Related]
16. Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.
Lui DTW; Chung MSH; Lau EHY; Lau KTK; Au ICH; Lee CH; Woo YC; Wong CKH; Cowling BJ
JAMA Netw Open; 2023 May; 6(5):e2314393. PubMed ID: 37204790
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study.
Ikeda S; Misumi T; Izumi S; Sakamoto K; Nishimura N; Ro S; Fukunaga K; Okamori S; Tachikawa N; Miyata N; Shinkai M; Shinoda M; Miyazaki Y; Iijima Y; Izumo T; Inomata M; Okamoto M; Yamaguchi T; Iwabuchi K; Masuda M; Takoi H; Oyamada Y; Fujitani S; Mineshita M; Ishii H; Nakagawa A; Yamaguchi N; Hibino M; Tsushima K; Nagai T; Ishikawa S; Ishikawa N; Kondoh Y; Yamazaki Y; Gocho K; Nishizawa T; Tsuzuku A; Yagi K; Shindo Y; Takeda Y; Yamanaka T; Ogura T
Sci Rep; 2021 May; 11(1):10727. PubMed ID: 34021229
[TBL] [Abstract][Full Text] [Related]
18. Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study.
Wong CKH; Au ICH; Lau KTK; Lau EHY; Cowling BJ; Leung GM
Lancet Infect Dis; 2022 Dec; 22(12):1681-1693. PubMed ID: 36029795
[TBL] [Abstract][Full Text] [Related]
19. Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection.
Kim DH; Park HC; Cho A; Kim J; Yun KS; Kim J; Lee YK
Medicine (Baltimore); 2021 May; 100(18):e25900. PubMed ID: 33951004
[TBL] [Abstract][Full Text] [Related]
20. Risk of Mortality in Elderly Coronavirus Disease 2019 Patients With Mental Health Disorders: A Nationwide Retrospective Study in South Korea.
Lee DY; Cho J; You SC; Park RW; Kim CS; Lee EY; Aizenstein H; Andreescu C; Karim H; Hong CH; Rho HW; Park B; Son SJ
Am J Geriatr Psychiatry; 2020 Dec; 28(12):1308-1316. PubMed ID: 33023798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]